LNDZF Company Profile and Key Details

Our AI price prediction model suggests that Salona Global Medical Device Corporation stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term.

Valuation shows Salona Global Medical Device Corporation trading at a premium to the broader market with a P/E of -0.0.

Dividend and splits history remains an important factor for investors monitoring long-term returns.

The stock is currently trading near its 52-week low $0.00 and $0.01. With a market capitalization of about $5.98 thousand, Evome Medical Technologies Inc. is classified as a micro-cap and shows higher-than-market volatility (beta ~1.30). Key stats such as the average daily volume over the past year has been around 9.22 thousand shares, in line with its 52-week average. Headquartered in Shirley, NY, Evome Medical Technologies Inc. operates in the Healthcare sector and the Medical - Devices industry. Led by CEO Christopher Heath, the company employs approximately 195 people and listed since September 17, 2015. Evome Medical Technologies Inc. is a global company that conceives, produces, and markets medical equipment across the Americas and other international markets.

Salona Global Medical Device Corporation trades at a P/E ratio of -0.0, slightly below the S&P 500 average, with a price-to-sales ratio of 0.0 The P/FCF stands at -0.01, also above market averages.